A randomized, double-blind study to compare the cardiovascular safety of allopurinol and febuxostat

  • STATUS
    None
Updated on 7 November 2020

Summary

A randomized, double-blind study to compare the cardiovascular safety of allopurinol and febuxostat

Description

A nine year study comparing the cardiovascular safety of allopurinol and febuxostat (Uloric) in patients with gout and cardiovascular comorbidities

Details
Condition Cardiovascular Abnormalities, Cardiovascular Abnormalities, Cardiovascular Abnormalities
Clinical Study IdentifierTX7610
Last Modified on7 November 2020

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note